Chemotherapy and Pelvic Hypofractionated Radiation Followed by Surgery Cervical Cancer
Phase II Randomized Study of Concurrent Chemotherapy and Pelvic Radiation Therapy With Standard Fractionated Compared to Hypofractionated Followed by Surgery for Patients With Locally Advanced Cervical Cancer.
Sponsor: National Institute of Cancerología
Listed as NCT03750539, this NA trial focuses on Cervix Cancer and remains ongoing. Sponsored by National Institute of Cancerología, it has been updated 9 times since 2017, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
9 versions recorded-
Jan 2026 — Present [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Sep 2024 — Jan 2026 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Dec 2023 — Jul 2024 [monthly]
Recruiting NA
Status: Unknown Status → Recruiting
-
Apr 2023 — Dec 2023 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
▶ Show 4 earlier versions
-
Apr 2021 — Apr 2023 [monthly]
Recruiting NA
-
Jan 2021 — Apr 2021 [monthly]
Recruiting NA
-
Sep 2020 — Jan 2021 [monthly]
Recruiting NA
Status: Active Not Recruiting → Recruiting
-
Dec 2018 — Sep 2020 [monthly]
Active Not Recruiting NA
First recorded
Nov 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Cancerología
For direct contact, visit the study record on ClinicalTrials.gov .